Dr. Sreevalli A is a medical oncologist in Kanakapura Road, Bangalore, currently practising as a Consultant – Medical Oncology at Manipal Hospital Kanakapura Road. With a strong academic background and wide-ranging clinical experience, Dr. Sreevalli has established herself as a top cancer specialist offering personalised and evidence-based care to patients across all stages of malignancy. Her areas of clinical focus span solid tumours, haematological malignancies, immunotherapy, and precision oncology.Dr. Sreevalli completed her MBBS from Sri Shamanur Shivashankarappa Institute of Medical Sciences & Research Centre, Davangere. She then pursued her MD in General Medicine from St. John’s Medical College, Bangalore, where she graduated with distinction and was honoured as the Best Outgoing Student in the Department of General Medicine. She stood fourth rank to Rajiv Gandhi University, Karnataka. Her academic excellence continued with a DM in Medical Oncology from the Kidwai Memorial Institute of Oncology, Bengaluru. During her DM, she secured the Gold Medal for achieving the first rank to Rajiv Gandhi university across the state of Karnataka. In addition, she holds the prestigious MRCP UK Speciality Certificate in Medical Oncology and is ESMO (European Society Of Medical Oncology) Certified.Her clinical training is complemented by extensive real-world experience. Dr. Sreevalli has served in both rural and urban healthcare settings. Early in her career, she provided primary healthcare in underserved regions near Davangere. She worked as a Senior Medical Registrar in Medical Oncology and later as a Consultant at a dedicated cancer hospital, where she led outpatient and inpatient oncology services and oversaw chemotherapy, immunotherapy, and palliative care pathways.Dr. Sreevalli has actively contributed to the field of oncology through her involvement in international multicentre clinical trials, serving as Co-Principal Investigator in multiple phase 1, 2, and 3 oncology studies. These include advanced studies on metastatic breast cancer, prostate cancer, and relapsed advanced malignancies. Her research interests include real-world outcomes in cancer therapeutics, immunotherapy and molecular profiling of tumours. Her publications in reputed journals such as the Journal of the National Comprehensive Cancer Network, Indian Journal of Cancer, Indian Journal of Medical and Paediatric Oncology, and Cancer Research, Statistics & Treatment reflect her deep commitment to oncology research.An accomplished presenter, Dr. Sreevalli has delivered oral and poster presentations at both national and global conferences. She was awarded a travel grant for her oral presentation titled "SUBCUTANEOUS PHESGO: THE WAY AHEAD INTO THE FUTURE” at the Indian Cancer Congress 2023. She was one among three Indians selected for the IASLC Academy 2025, a prestigious global programme recognising excellence in lung cancer care and research, with only 35 oncologists selected worldwide. Her case presentations on complex haematological and solid malignancies have been showcased at the NCCN Conference Florida 2024, European School of Haematology, ISMPOCON, ICON, Immuno-Oncology Society of India congresses, and Indian Cancer Congress.Dr. Sreevalli’s academic contributions include many original research publications and multiple journal reviews. She has served as a reviewer for journals such as IJMPO, CRST, JENCI, and IRJO, and was named the Second Best IJMPO Trainee Reviewer at ISMPOCON 2022. Her keen eye for clinical detail and critical analysis makes her a trusted academic contributor in oncology. Dr. Sreevalli is a strong advocate for cancer awareness and education. She regularly engages in public health outreach through newspaper articles, television and radio segments, and guest lectures at medical colleges and corporate forums. Her outreach work plays a vital role in demystifying cancer, promoting early detection, and supporting preventive health measures.Field of ExpertiseManagement Of Lung Cancer, Breast Cancer, Kidney And Other Urogenital Cancers, Gynaecological Cancers, Gastrointestinal Cancers, Head And Neck CancerPersonalised Cancer Treatment – Precision And Molecular OncologyTargeted Therapies In CancerImmunotherapy In CancerManagement Of Lymphomas, Myelomas, Chronic LeukemiasFellowship & MembershipESMO Certified (European Society of Medical Oncology)MRCP UK SCE (Medical Oncology)Member of the American Society of Clinical Oncology (ASCO)Member of the European Society of Medical Oncology (ESMO)Member of the International Association for Study of Lung Cancer (IASLC)Member of the Immuno-Oncology Society of India (IOSI)Member of the Indian Cooperative Oncology Network (ICON)Languages SpokenEnglishKannadaHindiTeluguTamilAwards & AchievementsGold Medal For Securing First Rank To Rajiv Gandhi University Of Health Sciences For The State Of Karnataka In DM Medical Oncology Final Exam 2022Best Outgoing Student In the Department Of General Medicine, St John’s Medical College, Bangalore, 2017. Secured Fourth Rank To Rajiv Gandhi University Of Health Sciences For The State Of Karnataka In MD General Medicine Final Exam 2017Selected For 2025 IASLC (International Association For The Study Of Lung Cancer) Academy Programme, One Among The Three Indians, Among Cohort Of 35 Physicians Around The World, To Participate In This Prestigious Programme Which Includes Attendance At The Next World Conference On Lung Cancer (WCLC) In Barcelona With A Project PresentationScored Highest In Paediatrics During MBBS 2012 At SSIMS DavangereCertificate Of Achievement From Harvard Medical School For Achieving 91% And Completing Online Course In HMX Progenetics – Cancer Genomics And Precision Oncology In November 2024Second Best IJMPO Trainee Reviewer (Indian Journal Of Medical And Paediatric Oncology) Among 2021 Trainee Reviewers All Over India At 8th ISMPOCON National Annual Conference 2022. Have Reviewed More Than 10 Articles Under Guidance Of Experts All Over India And Successfully Completed Trainee Reviewer ProgrammePresented Award Winning Research Papers At Multiple National And International Conferences Like Indian Cancer Congress, IOSICON, NCCN, ESMO, ESH, EtcTalks & PublicationsSreevalli Et Al, “CLO24-081: Induction Chemotherapy In Locally Advanced Squamous Cell Carcinoma Of Head And Neck – Biweekly Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (TPFL) Versus Triweekly TPF: Response Assessment And Translation Into Survival Benefit”. Journal Of The National Comprehensive Cancer Network 22, 2.5; 10.6004/jnccn.2023.7186A.H. Rudresha, Syed Adil Hassan, A. Sreevalli, D. Lokanatha, M.C. Suresh Babu Et Al. Prephase Strategy To Mitigate First-Cycle Effect In Diffuse Large B-Cell Lymphoma. Journal Of The Egyptian National Cancer Institute (2022) 34-20Linu Abraham Jacob, Sreevalli A, Shwetha Ninutha, Lokanatha Dasappa, Suresh Babu MC, Lokesh KN Et Al. Soft Tissue Sarcomas With Special Reference To Molecular Aberration, Chemotherapy And Recent Advances: A Review Article. Indian Journal Of Medical And Paediatric Oncology 2022MC Suresh Babu, A Sreevalli. Extranodal Diffuse Large B Cell Lymphoma – Real-World Experience From An Indian Tertiary Cancer Care Centre. Cancer Research, Statistics And Treatment 2022; 5:119-21Ratnamala Choudhry, Sreevalli A Et Al. Clinical And Laboratory Profile Of Acute Leukaemia With Special Reference To Flowcytometry. Medica Innovatica Jul-Dec 2017, Volume 6, Issue 2Choudhry SK, Sreevalli A, Jacob LA. Polypharmacy: A Common Yet Unaddressed Issue In Geriatric Oncology. Cancer Research, Statistics And Treatment 2021;4:405-6